GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » Revenue

Safeguard Scientifics (Safeguard Scientifics) Revenue : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics Revenue?

Safeguard Scientifics's revenue for the three months ended in Dec. 2023 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Safeguard Scientifics's Revenue per Share for the three months ended in Dec. 2023 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Safeguard Scientifics's highest 3-Year average Revenue per Share Growth Rate was 119.30% per year. The lowest was -61.80% per year. And the median was 11.70% per year.


Safeguard Scientifics Revenue Historical Data

The historical data trend for Safeguard Scientifics's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safeguard Scientifics Revenue Chart

Safeguard Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Safeguard Scientifics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Safeguard Scientifics's Revenue

For the Asset Management subindustry, Safeguard Scientifics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Safeguard Scientifics's Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Safeguard Scientifics's Revenue distribution charts can be found below:

* The bar in red indicates where Safeguard Scientifics's Revenue falls into.



Safeguard Scientifics Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Safeguard Scientifics  (OTCPK:SFES) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Safeguard Scientifics Revenue Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Safeguard Scientifics (Safeguard Scientifics) Business Description

Traded in Other Exchanges
Address
150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087
Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. Safeguard generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders.
Executives
Satterfield Thomas A Jr 10 percent owner 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont director 51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr. director 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Mark Herndon officer: SVP & Chief Financial Officer C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman officer: Chief Restructuring Officer C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert director C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts director 1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko officer: Senior V.P. & General Counsel 435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass director 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille officer: Senior VP & CFO C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison director C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli officer: Acting Sr VP & Acting CFO FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz director P O BOX 738, RYE NH 03870

Safeguard Scientifics (Safeguard Scientifics) Headlines

From GuruFocus

Q4 2022 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q2 2021 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q4 2018 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q4 2019 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Safeguard Scientifics, Inc. - Special Call Transcript

By GuruFocus Research 02-09-2024

Q1 2020 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2021 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q2 2022 Safeguard Scientifics Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Safeguard Scientifics, Inc. - Special Call Transcript

By GuruFocus Research 02-09-2024